These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11962655)

  • 21. Reinforced Mechanical Properties and Tunable Biodegradability in Nanoporous Cellulose Gels: Poly(L-lactide-co-caprolactone) Nanocomposites.
    Li K; Huang J; Gao H; Zhong Y; Cao X; Chen Y; Zhang L; Cai J
    Biomacromolecules; 2016 Apr; 17(4):1506-15. PubMed ID: 26955741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tailored degradation of biocompatible poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/calcium silicate/poly(lactide-co-glycolide) ternary composites: an in vitro study.
    Idaszek J; Zinn M; Obarzanek-Fojt M; Zell V; Swieszkowski W; Bruinink A
    Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4352-60. PubMed ID: 23910353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopic bone formation in and soft-tissue response to P(CL/DLLA)/bioactive glass composite scaffolds.
    Meretoja VV; Tirri T; Malin M; Seppälä JV; Närhi TO
    Clin Oral Implants Res; 2014 Feb; 25(2):159-64. PubMed ID: 23106633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and Effects on Dental Pulp Cells of a Polycaprolactone/Submicron Bioactive Glass Composite Scaffold.
    Wang S; Hu Q; Gao X; Dong Y
    J Endod; 2016 Jul; 42(7):1070-5. PubMed ID: 27325456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosslinked poly(epsilon-caprolactone/D,L-lactide)/bioactive glass composite scaffolds for bone tissue engineering.
    Meretoja VV; Helminen AO; Korventausta JJ; Haapa-aho V; Seppälä JV; Närhi TO
    J Biomed Mater Res A; 2006 May; 77(2):261-8. PubMed ID: 16392138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of the effects of different bioactive fillers in PLGA matrix composites and their suitability as bone substitute materials: A thermo-mechanical and in vitro investigation.
    Simpson RL; Nazhat SN; Blaker JJ; Bismarck A; Hill R; Boccaccini AR; Hansen UN; Amis AA
    J Mech Behav Biomed Mater; 2015 Oct; 50():277-89. PubMed ID: 26164218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vitro Degradation of Borosilicate Bioactive Glass and Poly(l-lactide-co-ε-caprolactone) Composite Scaffolds.
    Tainio J; Paakinaho K; Ahola N; Hannula M; Hyttinen J; Kellomäki M; Massera J
    Materials (Basel); 2017 Nov; 10(11):. PubMed ID: 29113141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers.
    Chouzouri G; Xanthos M
    Acta Biomater; 2007 Sep; 3(5):745-56. PubMed ID: 17392042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porous poly(alpha-hydroxyacid)/Bioglass composite scaffolds for bone tissue engineering. I: Preparation and in vitro characterisation.
    Maquet V; Boccaccini AR; Pravata L; Notingher I; Jérôme R
    Biomaterials; 2004 Aug; 25(18):4185-94. PubMed ID: 15046908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term in vitro testing on the properties of bioactive glass-polysulfone composites.
    Oréfice R; West J; Latorre G; Hench L; Brennan A
    Biomacromolecules; 2010 Mar; 11(3):657-65. PubMed ID: 20108891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of a bioactive and degradable poly(epsilon -caprolactone)/silica hybrid through a sol-gel method.
    Rhee SH; Choi JY; Kim HM
    Biomaterials; 2002 Dec; 23(24):4915-21. PubMed ID: 12361633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites.
    Misra SK; Mohn D; Brunner TJ; Stark WJ; Philip SE; Roy I; Salih V; Knowles JC; Boccaccini AR
    Biomaterials; 2008 Apr; 29(12):1750-61. PubMed ID: 18255139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphology of elastic poly(L-lactide-co-epsilon-caprolactone) copolymers and in vitro and in vivo degradation behavior of their scaffolds.
    Jeong SI; Kim BS; Lee YM; Ihn KJ; Kim SH; Kim YH
    Biomacromolecules; 2004; 5(4):1303-9. PubMed ID: 15244444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation and drug release of phosphate glass/polycaprolactone biological composites for hard-tissue regeneration.
    Kim HW; Lee EJ; Jun IK; Kim HE; Knowles JC
    J Biomed Mater Res B Appl Biomater; 2005 Oct; 75(1):34-41. PubMed ID: 16001393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass.
    Li H; Du R; Chang J
    J Biomater Appl; 2005 Oct; 20(2):137-55. PubMed ID: 16183674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poly(epsilon-caprolactone) and poly(epsilon-caprolactone)-polyvinylpyrrolidone-iodine blends as ureteral biomaterials: characterisation of mechanical and surface properties, degradation and resistance to encrustation in vitro.
    Jones DS; Djokic J; McCoy CP; Gorman SP
    Biomaterials; 2002 Dec; 23(23):4449-58. PubMed ID: 12322963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface modification of bioactive glass nanoparticles and the mechanical and biological properties of poly(L-lactide) composites.
    Liu A; Hong Z; Zhuang X; Chen X; Cui Y; Liu Y; Jing X
    Acta Biomater; 2008 Jul; 4(4):1005-15. PubMed ID: 18359672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
    Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
    Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization, degradation, and mechanical strength of poly(D,L-lactide-co-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-co-epsilon-caprolactone).
    Bramfeldt H; Sarazin P; Vermette P
    J Biomed Mater Res A; 2007 Nov; 83(2):503-11. PubMed ID: 17503493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(ε-caprolactone)/bioactive glass composite electrospun fibers for tissue engineering applications.
    Piatti E; Miola M; Liverani L; Verné E; Boccaccini AR
    J Biomed Mater Res A; 2023 Nov; 111(11):1692-1709. PubMed ID: 37300320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.